Inspection·February 19, 2026

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to provide pharmaceutical services including the accurate acquiring, receiving, dispensing, and administering of all drugs and biologicals to meet the needs of each resident for 2 of 5 residents (Resident #1 and Resident #2) reviewed for pharmacy services in that:The facility failed to ensure that a multidose vial of Ativan (a medication used to treat anxiety, agitation, and sometimes seizures), that had not been dated when opened, was not administered after the recommended 28 days from opening to Resident #1 on [DATE], [DATE], and [DATE], and Resident #2 on [DATE].These failures could place residents at risk for non-therapeutic responses to medications.Findings included:1. Record review of Resident #1's face sheet dated [DATE] revealed a [AGE] year-old male with an initial admission date of [DATE] and a current admission date of [DATE]. The pertinent diagnosis included Dementia with behavioral disturbances (a condition which affects memory, thinking, and the ability to perform daily activities, as well as could include symptoms such as agitation, aggression, delusions, and/or hallucinations). Record review of Resident #1's physician orders dated [DATE] revealed Ativan 2 MG/ML, inject 0.5 ML intramuscularly (administered within a muscle) one time only for aggression and combativeness. The physician order dated [DATE] revealed Ativan 2 MG/ML, inject 2 MG intramuscularly one time only for severe aggression, and the physician order dated [DATE] revealed Ativan 2 MG/ML, inject 0.5 ML intramuscularly one time only for aggression and combativeness.Record review of Resident #1's February 2026 MAR revealed IM Ativan was administered on [DATE] (by LVN-C), [DATE] (by RN-D), and [DATE] (by LVN-E).2. Record review of Resident #2's face sheet dated [DATE] revealed an [AGE] year-old female with an admission date of [DATE]. The pertinent diagnoses included Dementia with anxiety (a condition which affects memory, thinking, and the ability to perform daily activities, as well as could include symptoms such as anxiety), and Generalize Anxiety Disorder (nagging feelings of worry or anxiety). Record review of Resident #2's physician orders dated [DATE] (by LVN-C) revealed Ativan 2 MG/ML, give 0.5 ML one time only for aggression and combativeness. Record review of Resident #2's February 2026 MAR revealed Ativan 0.5 ML was administered on [DATE].In an observation on [DATE] at 11:29 AM, a multidose vial of Ativan was observed to be approximately 1/3 full with no written open date or initials on either the vial or the packaging. The vial expiration date was [DATE], but the vial had been opened on [DATE] (as noted on the Ativan Narcotic Count log that coincided with the vial of Ativan). In an interview on [DATE] at 2:15 PM, ADON-A stated multidose vials of medication should be dated and initialed on the vial by the nurse opening it as soon as it was opened. She also stated once the vial had been opened it was good for 28 days, then had to be discarded. ADON-A also stated the ADONs audit the controlled medication logs usually every couple of weeks, so she was not sure how the medication got missed. She also said the nurses were supposed to verify a medication was not expired prior to giving any medication because if the medication was expired it could make a resident sick, or the (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 455455 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 455455 B. Wing A. Building (X3) DATE SURVEY COMPLETED 02/19/2026 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Meridian Care of Alice 218 219 N King St Alice, TX 78332 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)